Composition for hair

A hair composition utilizing hair-adhering bacteria activates SIRT1 in scalp cells, addressing the unknown relationship between hair bacteria and human health, promoting hair growth and maintaining scalp health.

JP7583428B2Active Publication Date: 2024-11-14KYUSHU UNIV
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2020106053
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-06-19
Publication Date
2024-11-14
Estimated Expiration
2040-06-19

AI Technical Summary

Technical Problem

The relationship between resident hair bacteria and human health benefits has not been fully elucidated, limiting the utilization of these bacteria for hair and scalp health applications.

Method used

A composition containing cells, crushed cells, or components of hair-adhering bacteria such as Cutibacterium acnes, Pseudomonas lini, Pseudomonas alcaliphila, Staphylococcus epidermidis, and Staphylococcus argansis is developed to activate SIRT1 in scalp cells, promoting hair growth and maintaining scalp and hair health.

Benefits of technology

The composition effectively promotes hair growth, prevents hair loss, and maintains scalp health by activating SIRT1, a gene related to growth and aging of human epidermal cells, using bacteria commonly found on healthy individuals.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583428000008
    Figure 0007583428000008
  • Figure 0007583428000001
    Figure 0007583428000001
  • Figure 0007583428000002
    Figure 0007583428000002
Patent Text Reader

Abstract

To utilize a bacterium that is specifically fixed widely to hair and hair root of healthy human.SOLUTION: A composition for hair which includes a fungus body, a fungus body debris, or its component of a hair-adhered bacterium. A preferable example of the hair-adhered bacterium is selected from the group consisting of Pseudomonas lini, Pseudomonas alcaliphila, Pseudomonas antarctica, and Pseudomonas lundensis.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to the use of bacteria colonized in the hair of healthy individuals. The present invention is useful in the fields of hair cosmetic production, pharmaceutical composition production, medicine, health care, beauty, etc. [Background technology]

[0002] The human body has a variety of unique bacterial communities that inhabit various parts of the body, including the intestines, oral cavity, and skin. In particular, epidermal resident bacteria inhabit the epidermis, and while the organic acids they produce are beneficial to the host, such as preventing the invasion of exogenous pathogenic microorganisms, it is known that disruptions to the resident bacterial community structure can cause disease.

[0003] On the other hand, there are attempts to utilize bacterial metabolites and the like for hair and scalp. For example, Patent Document 1 proposes a hair composition containing a metabolite of a microorganism belonging to the genus Rhizopus or Monascus as an active ingredient. Patent Document 2 proposes the use of an extract of a strain of the species Pseudoalteromonas antarctica for cosmetic non-therapeutic treatment and / or care of the skin, mucous membrane and / or hair. Patent Document 3 also proposes a method for evaluating scalp redness and the like based on information on bacteria of the genus Corynebacterium in the scalp bacterial flora of the subject. Furthermore, Patent Document 4 proposes a composition for improving hair, which contains an antibody obtained using bacteria such as Staphylococcus aureus and Propionibacterium acnes that are present on the scalp or hair roots as an immunogen. It has also been reported that a lipopolysaccharide (LPS)-like substance produced by rice-derived Panthoea agglomerans promotes hair growth through activation of the immune system (Non-Patent Document 1).

[0004] Furthermore, with the development of human microbiome analysis, which comprehensively analyzes the microbial flora present in the human body, it has been shown that hair bacterial flora profiling may be applicable to identifying differences between individuals (Non-Patent Document 2). [Prior art documents] [Patent documents]

[0005] [Patent Document 1] JP 2012-72122 A (Patent No. 5780886) [Patent Document 2] JP 2018-500279 A [Patent Document 3] JP 2019-50799 A [Patent Document 4] JP 2020-63211 A [Non-patent literature]

[0006] [Non-Patent Document 1] K WAKAME, H OKAWA, K KOMATSU, A NAKATA, K SATO, H INGAWA, C KOHCHI, T NISHIZAWA and G SOMA, Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) Promotes Murine Hair Growth and Human Dermal Papilla Cell Gene Expression, Anticancer Research 36:3687-3692 (2016) [Non-Patent Document 2] Nishi, Eiji, Tashiro, Yukihiro, Sakai, Kenji. DNA analysis for human identity and DNA analysis in criminal investigations: Potential for new forensic techniques based on microbial community structure profiling. Kagaku to Seibutsu 55(8): 559-565 (2017) [Non-Patent Document 3] K Watanabe, E Nishi, Y Tashiro, and K Sakai,Mode and Structure of the Bacterial Community on Human Scalp Hair, Microbes Environ. 34(3):252-259 (2019) Summary of the Invention [Problem to be solved by the invention]

[0007] The present inventors have clarified the characteristics of hair-resident bacteria through community structure analysis of bacteria colonizing the hair of healthy individuals (Non-Patent Document 3). However, the relationship between these bacteria and humans has not been clarified. [Means for solving the problem]

[0008] The present inventors have found that certain hair-attaching bacteria are commonly colonized in many healthy individuals, and have further found that there is a beneficial relationship between such bacterial species commonly colonized in healthy individuals and humans, thus completing the present invention.

[0009] The present invention provides the following: [1] A composition for hair comprising any one of hair-attaching bacteria, a bacterial cell fragment, or a component thereof. [2] The composition described in 1, wherein the hair-attaching bacteria is any one selected from the group consisting of Cutibacterium acnes, Pseudomonas lini, Pseudomonas alcaliphila, Staphylococcus epidermidis, Staphylococcus argansis, Pseudomonas antarctica, and Pseudomonas lundensis. [3] The composition described in 1 or 2, wherein the hair-attached bacteria is any one selected from the group consisting of Pseudomonas lini, Pseudomonas alcaliphila, Pseudomonas antarctica, and Pseudomonas lundensis. [4] A composition described in any one of 1 to 3 for activating SIRT1 in scalp cells. [5] Any of the compositions described in 1 to 4, selected from the group consisting of compositions for hair growth, for thinning hair, for preventing hair loss, for promoting hair growth, for promoting hair growth, for hair care, for moisturizing hair, for keeping hair healthy, and for moisturizing the scalp. [6] A method for treating hair using any of the hair-attaching bacteria, its cells, crushed cells, or components thereof. [7] A method for treating hair by activating hair-attached bacteria. Effect of the Invention

[0010] The present invention makes it possible to utilize bacteria that colonize the hair of healthy individuals. The present invention can promote hair growth and keep the scalp and hair healthy. The present invention makes it possible to utilize bacteria that activate development- and aging-related genes in human epidermis-derived cells. [Brief description of the drawings]

[0011] [Figure 1] Identification of hair-attached bacteria that suppress and promote SIRT1 gene. The EGFP fluorescence intensity of DMSO is set to 1, and the relative fluorescence intensity of each sample is shown. DMSO and PBS are negative controls, and Resvelatrol is a positive control. For the bacterial samples, the cell suspension was labeled "dead" and the cell disruption solution was labeled "disrupted." The same test was performed three times and labeled A, B, and C. Statistical significance was defined as P <0.05 (* P <0.05; ** P <0.01; *** P <0.001) using t-test, and significance was shown by referring to the average P value of the triplicates. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] [Bacteria attached to hair] The hair composition of the present invention contains as an active ingredient any of the bacteria, cell fragments, or components thereof of hair-attached bacteria. In the present invention, hair refers to human hair unless otherwise specified. In the present invention, hair-attached bacteria refers to bacteria present in the hair root or hair shaft, and can be detected and identified by means of microscope observation, culture, DNA extraction, etc.

[0013] Examples of hair-attached bacteria that can be used in the present invention include Cutibacterium acnes, Pseudomonas lini, Pseudomonas alcaliphila, Staphylococcus epidermidis, Staphylococcus argansis, Pseudomonas antarctica, Pseudomonas lundensis, Pseudomonas caricapapayae, Staphylococcus argenteus, Lawsonella clevelandensis, Pseudomonas aeruginosa, Pseudomonas alkylphenolica, Delftia acidovorans, Pseudomonas beteli, Enhydrobacter aerosaccus, Undibacterium aquatile, Herbaspirillum aquaticum, Janthinobacterium agaricidamnosum, Morococcus cerebrosus, Comamonas jiangduensis, Acidovorax konjaci, Caenimonas terrae, Serratia marcescens, Acinetobacter guangdongensis, Acinetobacter bereziniae, Pseudomonas geniculata, Rhodanobacter glycinis, Amphritea balenae, Vicinamibacter silvestris, Thermodesulfovibrio aggregans, Chondromyces lanuginosus, Rhizobium daejeonense, Brevundimonas albigilva, Paracoccus aestuarii, Fusobacterium nucleatum, Streptococcus gordonii, Carnobacterium divergens, Gemella haemolysans, Clostridium subterminale, Dialister micraerophilus, Peptoniphilus koenoeneniae, Abiesfabri, Kouleothrix aurantiaca, Kocuria arsenatis, Arthrobacter alpinus, Corynebacterium propinquum, Corynebacterium tuberculostearicum, Propionimicrobium lymphophilum, Cutibacterium granulosum, Saccharothrix ecbatanensis, Williamsia marianensis, Actinophytocola algeriensis, Campylobacter ureolyticus, and Capnocytophaga granulosa (Non-Patent Document 3), and their molecular phylogenetic relatives. A molecularly phylogenetically closely related bacterium is a bacterium that belongs to the same genus as the above-mentioned bacterium and has a sequence identity of 96% or more, preferably 97% or more, more preferably 98% or more, and even more preferably 99% or more with any strain of the same species as the above-mentioned bacterium, in sequence analysis of a portion of about 500 bp upstream of the 16S rRNA gene, or a portion of at least 1300 bp or more, or the entire length of the gene.

[0014] Preferred examples of hair-attaching bacteria that can be used in the present invention include: Bacteria belonging to the genus Cutibacterium (e.g., P. acidifaciens, P. acidipropionici, P. acnes, P. australiense, P. avidum, C. cyclohexanicum, C. damnosum, C. freudenreichii, C. granulosum, C. jensenii, C. lymphophilum, C. microaerophilu, C. namnetense, C. olivae, C. propionicus, C. thoenii); Bacteria belonging to the genus Pseudomonas (e.g. P. agarici, P. asplenii, P. aurantiaca, P. aureofaciens, P. chlororaphis, P. corrugata, P. fragi, P. lundensis, P. taetrolens, P. antarctica, P. azotoformans, P. blatchfordae, P. brassicacearum, P. brenneri, P. cedrina, P. corrugata, P. fluorescens, P. gessardii, P. libanensis, P. mandelii, P. marginalis, P. mediterranea, P. meridiana, P. migulae, P. mucidolens, P. orientalis, P. panacis, P. protegens, P. proteolytica, P. rhodesiae, P. synxantha, P. thivervalensis, P. tolaasii, P. veronii, P. abietaniphila, P. acidophila, P. agarici, P. alcaliphila, P. alkanolytica, P. amyloderamosa, P. asplenii, P. azotifigens, P. cannabina, P. coenobios, P. congelans, P. costantinii, P. cruciviae, P. delhiensis, P. excibis, P. extremorientalis, P. frederiksbergensis, P. fuscovaginae, P. gelidicola, P. grimontii, P. indica, P. jessenii, P. jinjuensis, P. kilonensis, P. knackmussii, P. koreensis, P. lini, P. lutea, P. moraviensis, P. otitidis, P. pachastrellae, P. palleroniana, P. papaveris, P. peli, P. perolens, P. poae, P. pohangensis, P.protegens, P. psychrophila, P. psychrotolerans, P. rathonis, P. reptilivora, P. resiniphila, P. rhizosphaerae, P. rubescens, P. salomonii, P. segitis, P. septica, P. simiae, P. suis, P. thermotolerans, P. toyotomiensis, P. tremae, P. trivialis, P. turbinellae, P. tuticorinensis, P. umsongensis, P. vancouverensis, P. vranovensis, P. xanthomarina), and. Any one selected from the group consisting of bacteria belonging to the genus Staphylococcus (e.g., S. argenteus, S. arlettae, S. agnetis, S. aureus, S. auricularis, S. caeli, S. capitis, S. caprae, S. carnosus, S. caseolyticus, S. chromogenes, S. cohnii, S. cornubiensis, S. condimenti, S. debuckii, S. delphini, S. devriesei, S. edaphicus, S. epidermidis, S. equorum, S. felis, S. fleurettii, S. gallinarum, S. haemolyticus, S. hominis, S. hyicus, S. intermedius, S. jettensis, S. kloosii, S. leei, S. lentus, S. lugdunensis, S. lutrae, S. lyticans, S. massiliensis, S. microti, S. muscae, S. nepalensis, S. pasteuri, S. petrasii, S. pettenkoferi, S. piscifermentans, S. pseudintermedius, S. pseudolugdunensis, S. pulvereri, S. rostri, S. saccharolyticus, S. saprophyticus, S. schleiferi, S. schweitzeri, S. sciuri, S. simiae, S. simulans, S. stepanovicii, S. succinus, S. vitulinus, S. warneri, S. xylosus). More specifically, it is any one selected from the group consisting of Cutibacterium acnes, Pseudomonas lini, Pseudomonas alcaliphila, Staphylococcus epidermidis, Staphylococcus argansis, Pseudomonas antarctica, and Pseudomonas lundensis.These bacteria are species that predominantly colonize the hair of many healthy humans, and it is expected that the bacteria, their crushed bodies, or their components will have a favorable effect on hair.

[0015] More preferred examples of hair-attaching bacteria that can be used in the present invention are any selected from the group consisting of bacteria belonging to the genus Pseudomonas and bacteria belonging to the genus Staphylococcus. More specifically, any selected from the group consisting of Pseudomonas lini, Pseudomonas alcaliphila, Pseudomonas antarctica, and Pseudomonas lundensis. These are highly effective against hair.

[0016] The hair-attaching bacteria described above are used as the bacteria, the crushed bacteria, or the specific component contained in the crushed bacteria in the hair composition of the present invention. The bacteria may be live or dead, and may be a suspension in which the bacteria or the crushed bacteria are suspended in some liquid, or may be a dry product. When using the specific component contained in the crushed bacteria, it may be a solution.

[0017] The disrupted bacterial cells may be obtained by various disruption methods as long as the desired effect is maintained. Examples of disruption methods include mechanical disruption such as ultrasonic disruption, grinder disruption, osmotic disruption, and bead disruption, chemical disruption using surfactants, chaotropic agents, phenol, chloroform, and ethanol, and enzymatic disruption using proteases. After the disruption treatment, unnecessary fractions derived from bacteria and agents used for disruption may be removed by appropriate means. The disrupted bacterial cells may contain the whole bacterial cells or a part of the bacterial cells.

[0018] [Application] The composition of the present invention is for use on hair. In the present invention, the term "for use on hair" includes not only those for use on the hair (including the hair roots and hair shaft) itself, but also those for use on the scalp, unless otherwise specified.

[0019] The hair composition of the present invention can be used to activate sirtuin (SIRT) 1 in epidermal cells of the skin. Sirtuins have been attracting attention as important factors that exert anti-aging effects in various tissues. There are seven types of sirtuins (SIRT1 to SIRT7) in humans.

[0020] In the present invention, the term "activity of SIRT1" includes various cases in which SIRT1 activity is enhanced, unless otherwise specified. Specifically, activation of SIRT1 includes enhancement of SIRT1 gene expression and enhancement of SIRT1 activity as a histone deacetylase. Enhancement of SIRT1 gene expression includes upregulation of transcription from the gene to mRNA and upregulation of translation from the mRNA to protein.

[0021] Previously, it has been reported that lipopolysaccharide (LPS)-like substances produced by rice-derived Panthoea agglomerans promote hair growth by activating the immune system (Non-Patent Document 1), but there have been no examples of SIRT1 activation activity demonstrated using bacterial species that predominantly colonize the hair of many healthy humans.

[0022] SIRT1 is known to induce telomerase reverse transcriptase (TERT) in epidermal cells. TERT promotes hair growth by inducing hair cycle from telogen to anagen and by proliferating stem cells in the hair follicle bulge region. Therefore, by enhancing SIRT1 activity with the composition of the present invention, the hair composition of the present invention can be used for hair growth, thinning hair, preventing hair loss, promoting hair growth, promoting hair growth, nourishing hair, or keeping hair healthy.

[0023] The hair composition of the present invention can also be used for the treatment of hair-related diseases or conditions that are improved by activating SIRT1. In the present invention, the term "treatment" for a disease or condition includes reducing the risk of onset, delaying onset, prevention, treatment, and stopping or delaying progression. Treatment includes medical procedures performed by doctors for the purpose of treating a disease, and non-medical procedures performed by persons other than doctors, such as barbers, beauticians, beauty consultants, estheticians, cosmetics manufacturers, cosmetics sellers, etc. Treatment can also be performed by using, or recommending or instructing the use of, specific cosmetics, quasi-drugs, etc. The subject of treatment in the present invention includes humans (individuals), and is preferably a human for whom any of the above-mentioned treatments are desirable or who need to be treated.

[0024] The present invention also provides a method for treating hair by activating hair-attached bacteria. Since the cells of hair-attached bacteria, crushed cells, or specific components contained in the crushed cells have an effect on hair, it is expected that hair will be improved by activating such hair-attached bacteria.

[0025] [Composition] In the present invention, the term "composition" refers to the active ingredient itself, or the active ingredient and other ingredients, unless otherwise specified. The hair composition of the present invention may be a cosmetic, a quasi-drug, or a medicine, or may be an additive to be added to a cosmetic, a quasi-drug, or a medicine for hair.

[0026] The content of the active ingredients, microbial cells, disrupted microbial cells, or disrupted microbial cells, in the hair composition of the present invention can be appropriately adjusted. The content of these ingredients in the hair composition of the present invention is preferably 20% by mass or less, more preferably 10% by mass or less, and even more preferably 5% by weight or less.

[0027] The formulation of the hair composition is not particularly limited, and may be any formulation, such as liquid, foam, paste, cream, solid, powder, etc. Examples of formulations that are easy to apply to hair include aerosols, suspensions, liquids, pastes, and creams. More specific examples of forms include hair growth agents (liquids, aerosols), rinses, conditioning agents, treatment agents (including leave-in types), styling agents, and hair dyes.

[0028] In addition to the active ingredient, the fungus body, disrupted fungus body, or disrupted fungus body, the hair composition of the present invention may contain various ingredients that are usually incorporated into hair compositions and are acceptable for cosmetics or pharmaceuticals, so long as they do not impair the intended effect. Examples of such ingredients include moisturizers, vitamins, bactericides, anti-inflammatory agents, anti-dandruff agents, preservatives, chelating agents, dyes, colorants, fragrances, ultraviolet absorbers, antioxidants, extracts, pearlizing agents, shea butter, rose water, sunflower oil, orange oil, eucalyptus oil, surfactants, and oils. As the surfactant, any of cationic surfactants, anionic surfactants, amphoteric surfactants, and nonionic surfactants can be used. Examples of cationic surfactants include alkylamine salts and alkyl quaternary ammonium salts. Examples of anionic surfactants include alkyl sulfonates, alkyl carboxylates, alkyl ether sulfonates, and alkyl ether carboxylates. Examples of amphoteric surfactants include imidazoline, carbobetaine, amidobetaine, sulfobetaine, hydroxysulfobetaine, and amidosulfobetaine. Examples of nonionic surfactants include esters such as glycerin fatty acid esters, sorbitan fatty acid esters, and sucrose fatty acid esters, and ethers such as polyoxyethylene alkyl ethers, polyoxyethylene alkylphenyl ethers, polyoxyethylene-polyoxypropylene alkyl ethers, and polyoxyethylene-polyoxypropylene alkylphenyl ethers. Examples of oils include hydrocarbons such as squalene, squalane, liquid paraffin, liquid isoparaffin, and cycloparaffin; glycerides such as castor oil, cocoa oil, mink oil, avocado oil, and olive oil; waxes such as beeswax, spermaceti, lanolin, and carnauba wax; esters such as isopropyl palmitate, isopropyl myristate, octyldodecyl myristate, hexyl laurate, cetyl lactate, propylene glycol monostearate, oleyl oleate, hexadecyl 2-ethylhexanoate, isononyl isononanoate, and tridecyl isononanoate; and higher fatty acids such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, coconut oil fatty acid, lanolin fatty acid, isostearyl acid, and isopalmitic acid.

[0029] The hair composition of the present invention can be manufactured using various known techniques. The active ingredient can be added at various stages of the manufacturing process as long as the desired effect is not impaired. Those skilled in the art can appropriately design the manufacturing process for the hair composition of the present invention, taking into account the solubility, stability, volatility, etc. of the active ingredient.

[0030] The method of using the hair composition of the present invention is not particularly limited as long as the intended effect is not impaired, and can be appropriately selected depending on the type, formulation, etc., but from the viewpoint of effectively exerting the effects of the present invention, it may be preferable to apply the composition to clean hair after washing. A specific method of use includes, for example, applying the hair composition to the scalp and hair after washing, allowing it to blend, and then massaging it as necessary.

[0031] The amount of the hair composition of the present invention that is applied to hair is not particularly limited, so long as the intended effect is not impaired.

[0032] The hair composition of the present invention and its products can be labeled with information such as that it contains an active ingredient, that it contains a large amount of the active ingredient, that the effect expected from the active ingredient is, and that its use is recommended for a specific target. Labeling can be direct or indirect, and examples of direct labeling include descriptions on tangible objects such as the product itself, packaging, containers, labels, and tags, while examples of indirect labeling include advertising and promotional activities by place or means such as websites, storefronts, pamphlets, exhibitions, books, newspapers, magazines, television, radio, mailings, e-mails, and voice. The present invention will now be described in more detail with reference to examples. EXAMPLES

[0033] 1. Experimental Procedure 1-1 Analysis of bacterial community structure on human hair 1-1-1 Hair sampling Hair samples were collected from adult men and women who agreed to participate in the experiment. To collect hair shafts, the top of the hair was cut off 5 mm from the scalp using stainless steel scissors while wearing nitrile gloves. The collected hairs were then cut into approximately 5 mm pieces and used for bacterial count and community structure analysis.

[0034] 1-1-2 DNA extraction from hair-attached bacteria Lysozyme solution (lysozyme from egg white (Wako Osaka) 20 mg / ml 20 mM Tris-HCl (Wako Osaka) 0.2 mM EDTA (Wako Osaka)) was added and incubated at 37 ° C for 30 minutes. After treating at 70 ° C for 10 minutes to inactivate lysozyme, DNA extraction was performed using NucleoSpin (registered trademark) Tissue (MACHEREY-NAGEL Company).

[0035] 1-1-3 Nested PCR To perform amplicon analysis of the V4 region of the 16S rRNA gene of bacterial DNA using MiSeq, template DNA was amplified by nested PCR using universal primers. KAPA HiFi HotStart ReadyMix (NIPPON Genetics Tokyo) was used as the reaction solution. The nested PCR reaction conditions were initial denaturation at 95°C for 3 minutes, denaturation at 95°C for 30 seconds, annealing at 56°C for 30 seconds, extension at 72°C for 30 seconds, and final extension at 72°C for 5 minutes, with 40 cycles from denaturation to extension.

[0036] [Table 1]

[0037] 1-1-4 Obtaining the target product and purifying DNA After the PCR reaction, the products were confirmed by 1.5% agarose gel electrophoresis. The target long-chain DNA was separated from the gel using the Gel DocTM XR + system (BioRad America) and purified using the FastGeneTM Gel / PCR Extraction Kit (NIPPON Genetics Tokyo).

[0038] 1-1-5 1st Tailored PCR PCR was performed to add a tailed sequence to the purified DNA. The primer sequences are shown below. The 1st PCR Primer was treated at 95°C for 5 minutes, and KAPA HiFi HotStart ReadyMix (NIPPON Genetics Tokyo) was used to prepare a reaction solution. The reaction conditions were initial denaturation at 95°C for 3 minutes, denaturation at 98°C for 30 seconds, annealing at 55°C for 30 seconds, extension at 72°C for 30 seconds, and final extension at 72°C for 5 minutes, with 10 cycles from denaturation to extension.

[0039] After the PCR reaction, 1.5% agarose gel electrophoresis was performed to confirm the amplification of approximately 350 bp. TM The PCR products were purified using a Gel / PCR Extraction Kit (NIPPON Genetics Tokyo).

[0040] [Table 2]

[0041] 1-1-6 2nd Tailed PCR In order to add an index sequence to distinguish each sample to the amplified DNA after the first PCR, a second PCR was performed. The 9 forward and 12 reverse primers used are listed below.

[0042] [Table 3]

[0043] The reaction conditions were the same as for the 1st Tailed PCR, and eight cycles from denaturation to extension were performed. After the PCR reaction, amplification was confirmed by 1.5% agarose gel electrophoresis. To remove the chimeric products, the gel was excised and the PCR products were purified in the same manner as for the Nested PCR.

[0044] 1-1-7 2nd PCR amplified DNA concentration measurement To adjust the concentration of the DNA library for sequencing analysis using MiSeq, the concentration of the 2nd PCR amplified DNA was measured using a Qubit (registered trademark) 3.0 Fluorometer (Thermo Fisher Scientific America) and a Qubit (registered trademark) dsDNA HS Assay Kit (Thermo Fisher Scientific America).

[0045] 1-1-8 DNA library preparation and analysis using MiSeq The 2nd PCR amplified DNA with the measured concentration was mixed and adjusted to a final concentration of 4 nM using MiSeq Reagent Kit V3 (600 cycles) (Illumina America). Sequencing was then performed using a MiSeq sequencer (Illumina America).

[0046] OTU clustering by USEARCH The base sequence data obtained by MiSeq was clustered into operational taxonomic units (OTUs) with homology of 97% or more using the statistical analysis software USEARCH (https: / / www.drive5.com / usearch / ).

[0047] 1-1-9 Phylogenetic analysis using QIIME Using the OTU table created by USEARCH, we added phylogenetic information based on the database, and analyzed α diversity, which indicates the species diversity per sample, and β diversity, which indicates the diversity between samples.

[0048] 1-2 Investigation of the activity of growth and aging-related genes in human epidermal cells using bacteria 1-2-1 Bacteria sample The bacteria used were selected from the major bacteria that emerged in the bacterial flora analysis and were purchased from a microorganism preservation institution and cultured. All bacteria were standard strains. The bacteria used in this study are shown in the table below.

[0049] Bacteria were cultured under appropriate conditions, and the cells were collected by centrifugation, washed three times with phosphate buffered saline (PBS(-)), and resuspended in PBS. The suspension was heated at 90°C for 30 minutes, and then freeze-dried. The freeze-dried bacteria were resuspended in PBS to an appropriate concentration. The suspension was also sonicated to prepare a cell lysate, and two samples were prepared for each type of bacteria.

[0050] [Table 4]

[0051] 1-2-2 Cultivation of human epidermal cells In this experiment, HaCaT cells were used as a model cell for human skin. The cells were subcultured in DMEM medium (Dulbecco's Modified Eagle Medium; Nissui Tokyo Japan) supplemented with inactivated 10% fetal bovine serum (FBS; Life Technologies CA USA) in a cell culture dish (Greiner bio-one Tokyo Japan) at 37°C and 5% CO2.

[0052] 1-2-3 Development and aging-related gene SIRT1 promoter The human SIRT1 promoter (−1593 to −1) was amplified by PCR using human genomic DNA as a template, and the fragment was cloned into pEGFP-C3 (TaKaRa Bio Inc., Shiga, Japan) and named pSIRT1p-EGFP (hereafter HaCaT).

[0053] 1-2-4 Screening of bacteria that exhibit growth and aging-related gene activity Bacterial samples were added to the transduced HaCaT cells and human SIRT1 promoter activity was assessed.

[0054] HaCaT cells were seeded onto a 96-well plate, and samples were added 24 hours later. Each sample was added to three wells, and changes in EGFP fluorescence derived from pSIRT1p-EGFP were monitored 48 hours later using an IN Cell Analyzer 2200 (GE Healthcare, Little Chalfont, UK).

[0055] Resvelatrol was used as a positive control, and its solvent, DMSO, and PBS, a bacterial suspension solvent, were used as negative controls. In addition, a lipopolysaccharide compound (IP-PA1) derived from Pantoea agglomerans was used as an indicator of bacteria because it has the effect of promoting hair growth in human hair papilla cells (K. Wakame et al., 2016). The bacteria used and prepared from the main hair-attaching bacteria are listed in the table above.

[0056] 1-2-5 Statistical analysis Experiments were performed at least three times, and statistical significance was defined as P < 0.05 using t-test (* P < 0.05; ** P < 0.01; *** P < 0.001).

[0057] 2. Results and discussion 2.1 Identification of human hair-associated bacteria that activate SIRT1 transcription HaCaT cells showed an increase in EGFP fluorescence intensity upon addition of the major hair-attaching bacteria (Figure 1). In particular, Pseudomonas lini, Pseudomonas epidermidis, Pseudomonas antarctica, and Pseudomonas lundensis were found to significantly enhance SIRT1 expression in HaCaT cells.

[0058] In addition, differences in EGFP fluorescence intensity were observed between cell suspensions and cell lysates depending on the bacteria. When human intestinal cells and lactic acid bacteria were used, it has been reported that some strains of dead bacteria enhance SIRT1 activity (Gakuro Harada, Pawat Pattarawat, Kenji Ito, Takashi Matsumoto, Takanori Hasegawa, Yoshinori Katakura, Lactobacillus brevis T2102 suppresses the growth of colorectal cancer cells by activating SIRT1, Journal of Functional Foods, 23, 444-452 (2016)). In the case of hair-attached bacteria, human epidermal cells were able to activate SIRT1 not only with bacterial products but also with dead bacteria alone, suggesting that the presence of bacteria itself has an effect on epidermal cells.

[0059] In addition, the SIRT1 gene whose activity was confirmed in this study is known to induce telomerase reverse transcriptase (TERT) in the epidermis. TERT promotes hair growth by inducing the hair cycle from telogen to anagen and by proliferating stem cells in the hair follicle bulge region (Sarin KY, Cheung P, Gilison D., Lee E., Tennen RI., Wang E., Artandi MK., Oro AE., Artandi SE., Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature. 436(7053), 1048-1052(2005)). Therefore, it was suggested that the presence of human hair-attached bacteria may enhance SIRT1 activity and promote hair growth.

[0060] These findings suggest that hair-associated bacteria include bacteria that activate SIRT1 in human epidermal cells, and that a beneficial relationship exists between hair-associated bacteria and humans.

[0061] For each of the three studies, A, B, and C, the numerical data of EGFP fluorescence obtained using the IN Cell Analyzer 2200 are shown as the mean relative value relative to DMSO, the standard deviation, and the result of a t-test. Statistical significance was defined as P < 0.05 (* P < 0.05; ** P < 0.01; *** P < 0.001) using a t-test. Values ​​are rounded to the fourth decimal place.

[0062] [Table 5]

[0063] [Table 6]

[0064] [Table 7] [Industrial Applicability]

[0065] This invention is expected to lead to the development of new hair care products, such as methods or products for activating genes related to the growth and aging of human epidermal or hair root cells, using live or dead cell suspensions of bacteria that specifically colonize broadly in healthy human hair and hair roots, or cell lysates or their specific components.

Claims

1. A composition for hair comprising any one of the hair-attaching bacteria, or a disrupted body of the hair-attaching bacteria, wherein the hair-attaching bacteria is any one selected from the group consisting of Pseudomonas lini, Pseudomonas alcaliphila, Pseudomonas antarctica, and Pseudomonas lundensis.

2. The composition of claim 1 for activating SIRT1 in scalp cells.

3. The composition according to claim 1 or 2, which is for any one of the purposes selected from the group consisting of hair growth, thinning hair, prevention of hair loss, promotion of hair growth, promotion of hair growth, hair care, and keeping hair healthy.

4. A method for treating hair using cells or cell fragments of any of the hair-attached bacteria, wherein the hair-attached bacteria is any one selected from the group consisting of Pseudomonas lini, Pseudomonas alcaliphila, Pseudomonas antarctica, and Pseudomonas lundensis (however, medical procedures are excluded).

Citation Information

Patent Citations

  • Television receiver

    JP1982080886A

  • Cosmetic for nourishing hair

    JP1983225006A

  • Hair cosmetic

    JP1985139609A

  • Composition for hair

    JP2012072122A

  • Cosmetic and / or pharmaceutical composition containing bacterial extracellular products from pseudoalteromonas antarctica and uses thereof

    JP2018500279A